Dexcom (Nasdaq:DXCM) announced that its G6 continuous glucose monitoring (CGM) system will be available through Tricare.

San Diego-based Dexcom’s CGM will be more easily available to military members, their families and retirees with diabetes as a Tricare brand-name formulary pharmacy benefit.

According to a news release, effective mid-April 2022, members with diabetes will be eligible for the Dexcom G6 CGM through the military treatment facility pharmacies at zero copayment, the Tricare retail pharmacy network at a $38 copayment per 30-day supply or through the mail-order/home delivery at a copayment of $34 per 90-day supply.

Dexcom’s G6 was previously available through the Tricare medical benefit by durable medical equipment suppliers, with varying copayment amounts based on the plan. The company said the pharmacy benefit offers a faster process and more consistent copayments for members.

“We are thrilled to make Dexcom G6 more easily accessible to the many military members and their families who rely on Tricare,” Dexcom Chair, President and CEO Kevin Sayer said in the release. “With the pharmacy benefit, Tricare beneficiaries with diabetes can use this game-changing technology to make informed, real-time decisions about their health with little to no out-of-pocket costs.”